Amylyx Pharmaceuticals, Inc. ($AMLX)
Filing Information
| Accession Number | 0001193125-26-017056 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 21, 2026 |
| Document Date | Jan 15, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
538,188
Total Value
$3,391,569.83
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 15, 2026 | Exercise/Conversion | 197,153 | $7.57 | $1,492,448.21 | 3,514,739 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 15, 2026 | Sale | 136,193 | $13.58 | $1,849,868.66 | 3,378,546 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 16, 2026 | Exercise/Conversion | 2,847 | $7.57 | $21,551.79 | 3,381,393 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 16, 2026 | Sale | 1,995 | $13.89 | $27,701.17 | 3,379,398 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 15, 2026 | Exercise/Conversion | 197,153 | $0.00 | $0.00 | 2,847 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 16, 2026 | Exercise/Conversion | 2,847 | $0.00 | $0.00 | 0 | Direct | โ | View Details |